The palatability of commercially available hyoscine butyl bromide syrups for paediatric use in South Africa: Comparative assessment using an electronic tongue
{{output}}
Patient rejection of unpalatable products can adversely affect therapeutic adherence, potentially leading to treatment failure. Taste masking is a goal in pharmaceutical development, particularly when developing formulations for paediatric patients. The use of... ...
